July 14, 2026 · Form 4 insider transaction
Vivo Opportunity, LLC bought 493 shares of InMed Pharmaceuticals Inc. at $1.55 per share, a transaction worth $764.15. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P., the record holder of the securities. Vivo Opportunity Cayman, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.